HT
TEVA icon

Heritage Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Heritage Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-848
Closed -$13K – 390
2018
Q4 		$13K Sell
848
-324
-28% -$6.64K 0.01% 291
2018
Q3 		$25K Hold
1,172
– – 0.01% 250
2018
Q2 		$29K Hold
1,172
– – 0.01% 237
2018
Q1 		$20K Buy
1,172
+972
+486% +$19K 0.01% 248
2017
Q4 		$4K Hold
200
– – ﹤0.01% 337
2017
Q3 		$4K Sell
200
-15,257
-99% -$343K ﹤0.01% 339
2017
Q2 		$514K Buy
15,457
+6,578
+74% +$204K 0.2% 76
2017
Q1 		$285K Buy
+8,879
New +$303K 0.11% 100

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heritage Trust's TEVA Position: Q1 2019 in Review

Heritage Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 848 shares — an estimated $13K sold.

Heritage Trust first reported a position in TEVA in Q1 2017 and held it in 8 quarters. The position peaked at $514K in Q2 2017. 521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Heritage Trust reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Heritage Trust sold 848 Teva Pharmaceuticals shares in Q1 2019, an estimated $13K.
  • Heritage Trust first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Heritage Trust's Teva Pharmaceuticals position peaked at $514K in Q2 2017.
  • 521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Heritage Trust's 13F filing for Q1 2019, filed 15 May 2019.